Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Emma

Emma Ahlqvist, Lund SE

Patent application numberDescriptionPublished
20110200993NEW TREATMENT OF AUTOIMMUNE CONDITIONS - The invention relates to methods and materials involved in diagnosing and treating autoimmune conditions. In particular, the invention relates to methods and materials involved in identifying agent suitable for the prophylaxis, prevention and/or treatment of an autoimmune condition. The invention further relates to methods and materials involved in diagnosing autoimmune diseases like arthritis, multiple sclerosis and inflammatory bowels disease accompanied by decreased cellular uptake of amino acids caused by defects in cellular amino acid transporters like Slc38A1 (Solute carrier family 38, member 1). The invention also relates to methods and materials involved in diagnosing, treating, preventing, or delaying the onset and ameliorating the symptoms of autoimmune conditions that are accompanied by defects in cellular amino acid transporters.08-18-2011

Emma Arzola, Tulare, CA US

Patent application numberDescriptionPublished
20090057332Food container having separate refuse disposal receptacle - A food container configured for use with food products having a refuse component, such as sunflower and other products having shells and fruit or other products having nonedible seeds or pits. The food container comprises a lower receptacle having a chamber configured to store a quantity of food product, an upper receptacle having a chamber configured to receive and store the refuse, a dispensing mechanism at a dispensing opening in the lower receptacle for dispensing the food product therefrom and a lid at the upper receptacle for enclosing the refuse. In a preferred embodiment, the lower end of the upper receptacle is removably received in an opening at the upper end of the lower receptacle and connected thereto to form a single food container unit. The dispensing mechanism can be a openable tab member or a rotatable dispensing member having an outlet aperture that is aligned with the dispensing opening.03-05-2009

Emma Barchiesi, Cusano Milanino IT

Patent application numberDescriptionPublished
20100133482Vinylidene fluoride copolymers - The present invention pertains to a linear semi-crystalline copolymer [polymer (A)] comprising recurring units derived from vinylidene fluoride (VDF) monomer and at least one hydrophilic (meth)acrylic monomer (MA) of formula (I) wherein each of R1, R2, R3, equal or different from each other, is independently an hydrogen atom or a C06-03-2010

Emma Bratt, Molndal SE

Patent application numberDescriptionPublished
200901118221,2,3-TRIAZOLE PYRROLIDINE DERIVATIVES AS MODULATORS OF MGLUR5 - The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.04-30-2009
20090111824AMIDE LINKED HETEROAROMATIC DERIVATIVES AS MODULATORS OF MGLUR5 - The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.04-30-2009

Emma Brown, Eagley GB

Patent application numberDescriptionPublished
20090056899BELT FOR A MACHINE FOR THE PRODUCTION OF WEB MATERIAL, SPECIFICALLY PAPER OR CARDBOARD - The invention relates to a belt for a machine for the production of web material, especially paper or cardboard, including a carrying structure and a pattern of wear-resistant material on at least one side of the carrying structure. The invention further relates to a machine for the production of a fibrous web in which the inventive belt is utilized.03-05-2009

Emma Butin, Tel Aviv IL

Patent application numberDescriptionPublished
20110047462DISPLAY-INDEPENDENT COMPUTERIZED GUIDANCE - A method for display-independent execution of a computerized guidance script, the method comprising capturing a screenshot of a graphical user interface (GUI) of a computerized application, analyzing the screenshot for matching a control of the screenshot with a control of the guidance script, and executing the guidance script, based on the matching, to operate the computerized application. Additionally, a display-independent computerized guidance engine, comprising a screenshot analysis engine and a guidance script execution engine.02-24-2011
20110047488DISPLAY-INDEPENDENT RECOGNITION OF GRAPHICAL USER INTERFACE CONTROL - A method for display-independent recognition of a graphical user interface (GUI) control, the method comprising capturing a screenshot of a GUI of a computerized application, determining a cursor position in the screenshot, analyzing an area surrounding the cursor position, to identify a GUI control, and storing an image of the GUI control.02-24-2011
20110047514RECORDING DISPLAY-INDEPENDENT COMPUTERIZED GUIDANCE - A method for recording a display-independent computerized guidance script, the method comprising capturing a screenshot of a GUI of a computerized application, analyzing an area, in the screenshot, surrounding a determined cursor position, to identify a GUI control, recording a manual operation sequence of the computerized application, and assigning the GUI control to a step of the operation sequence.02-24-2011

Emma Doud, Cambridge, MA US

Patent application numberDescriptionPublished
20110136759MOENOMYCIN ANALOGS, METHODS OF SYNTHESIS, AND USES THEREOF - The present invention provides novel moenomycin analogs as well as pharmaceutical compositions thereof, methods of synthesis, and methods of use in treating an infection by administering an inventive compound to a subject in need thereof. The moenomycin analogs may be prepared synthetically, biosynthetically, or semi-synthetically. The analogs are particularly useful in treating or preventing infections caused by Gram-positive organisms. Certain inventive compounds may have a broader spectrum of coverage, which includes Gram-negative organisms.06-09-2011

Emma Farndon, Loughborough GB

Patent application numberDescriptionPublished
20110039170FUEL CELLS - The present invention concerns a fuel cell comprising a cathode in a cathode region of the cell and an anode in an anode region of the cell, the cathode being separated from the anode by an ion selective polymer electrolyte membrane, the cathode region of the cell being supplied in use thereof with an oxidant and a liquid low molecular weight fuel wherein at least some of the liquid low molecular weight fuel in use crosses the polymer electrolyte membrane to supply the anode region of the cell with liquid low molecular weight fuel, the cell being provided with means for generating an electrical circuit between the cathode and the anode.02-17-2011

Emma Iomdina, Houston, TX US

Patent application numberDescriptionPublished
20120059586DTEM With Short Spacing for Deep, Ahead of the Drill Bit Measurements - A transmitter on a bottomhole assembly (BHA) is used for generating a transient electromagnetic signal in an earth formation. A processor estimates the distance to a resistivity interface using a signal produced by a receiver on the BHA. The transmitter-receiver distance may be less than 1 m. The estimation of the distance is done in real time using a thin conductive sheet approximation.03-08-2012

Emma Ito, Toronto CA

Patent application numberDescriptionPublished
20120094900SENSITIZING AGENTS FOR CANCER THERAPY, METHODS OF USE AND METHODS FOR THE IDENTIFICATION THEREOF - There is provided herein methods, compounds and methods for identifying compounds, for sensitizing a subject with cancer to a cancer therapy by inhibiting or down-regulating UROD.04-19-2012

Emma Jaikaran, Cambridge GB

Patent application numberDescriptionPublished
20080213262Inhibition of Islet Amyloid Polypeptide (Iapp) Aggregation for the Treatment of Type 2 Diabetes - The present invention relates to the targeting and clearance of soluable unprocessed Islet Amyloid Polypeptide (hIAPP) in order to prevent the nucleation of hIAPP amyloidogenesis and to interfere with pancreatic cell death which is associated with the aggregation of hIAPP. Agents and methods for reducing hIAPP aggregation are provided herein and may be useful in the treatment of type 2 diabetes.09-04-2008

Emma Kendrick, Hampshire GB

Patent application numberDescriptionPublished
20110198532LITHIUM-CONTAINING TRANSITION METAL SULFIDE COMPOUNDS - The present invention provides a convenient process for making lithium-containing transition metal sulfides involving heating at least on transition metal sulfide with a lithium-containing compound, wherein the lithium-containing compound is selected from one or more of lithium oxide, lithium sulfate, lithium carbonate, anhydrous lithium hydroxide, lithium hydroxide monohydrate, lithium oxalate, lithium nitrate, and any material that is a precursor for any of these lithium-containing compounds.08-18-2011
20110200878LITHIUM CONTAINING TRANSITION METAL SULFIDE COMPOUNDS - The present invention provides composition comprising at least one lithium-containing transition metal sulfide and carbon, wherein particles of the carbon are dispersed at the microscopic level on individual particles of the lithium-containing transition metal sulfide.08-18-2011
20110200882LITHIUM CONTAINING TRANSITION METAL SULFIDE COMPOUNDS - The present invention provides a convenient process for making lithium-containing transition metal sulfides involving heating at least one transition metal sulfide with lithium sulfate or any material that is a precursor for lithium sulfate, under reducing reaction conditions, wherein the oxidation state of the transition metal is not reduced during the reaction process.08-18-2011
20110206600PREPARATION OF LITHIUM SULFIDE - The present invention provides a convenient process for making lithium sulfide involving heating one or more lithium-containing compounds and sulphur, wherein the heating step is performed at a temperature of 600 to 1500° C.08-25-2011

Emma Kvitnitsky, Kiriat Shemona IL

Patent application numberDescriptionPublished
20100092586Natural water soluble extracts for the inhibition of alpha-1-adrenergic receptors - The present invention discloses therapeutic natural products, in particular plant extracts effective in treating and preventing urinary tract disorders, and method for obtaining said extracts. In particular, the present invention discloses a water-soluble alcoholic extract of 04-15-2010

Emma Kvitnitsky, Kiryat Shmona IL

Patent application numberDescriptionPublished
20110229536COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING MICROENCAPSULATED COLORANTS - Color-changing cosmetic or therapeutic compositions for topical application are provided, comprising one or more active substances and one or more microencapsulated colorants, which upon application on the skin provide a changing color effect that indicates the delivery of the active substances from said composition onto the skin and/or gives to the skin a visual esthetical effect.09-22-2011

Emma Lee-Smith, Norfolk GB

Patent application numberDescriptionPublished
20090230322FLUORESCENCE BASED DETECTION OF SUBSTANCES - A method for the fluorescent detection of a substance, the method comprising providing particles comprising a metal or a metal oxide core, wherein one or more optionally fluorescently tagged antibodies or human specific peptide nucleic acid (PNA) oligomers for binding to a substance is/are bound, directly or indirectly, to the surface of the metal or metal oxide; contacting a substrate, which may or may not have the substance on its surface, with the particles for a time sufficient to allow the antibody/PNA oligomer to bind with the substance; removing those particles which have not bound to the substrate; if the antibodies or PNA oligomers are not fluorescently tagged, contacting the substrate with one or more fluorophores that selectively bind with the antibody and/or substance, then optionally washing the substrate to remove unbound fluorophores; and illuminating the substrate with appropriate radiation to show the fluorophores on the substrate.09-17-2009

Emma Masteller, San Francisco, CA US

Patent application numberDescriptionPublished
20100310588REGULATORY T CELLS SUPPRESS AUTOIMMUNITY - The invention provides methods for producing an autoantigen-specific regulatory T cell enriched composition, and resultant compositions and methods for use.12-09-2010

Emma Perfect, Edinburgh GB

Patent application numberDescriptionPublished
20100034750COMPOSITION AND METHOD FOR DETECTION OF DEMINERALISATION - The invention relates to a composition for the detection of tooth demineralisation. More specifically, the invention concerns a composition comprising a complex capable of producing an optical signal characteristic of the presence of free ions, the pharmaceutical uses of such a composition, and methods and a kit for the detection of active demineralisation at tooth surfaces using such a composition.02-11-2010
20100304418Compositions and Methods for Monitoring Flow Through Fluid Conducting and Containment Systems - Latently detectable tracers for use in fluid conducting and containment systems wherein the interaction between the tracer and a biomacromolecule produces a detectable signal. More specifically, the latently detectable tracers monitor flow through such systems. Methods for monitoring the flow of fluid using the tracers, and a kit for use in monitoring the flow of fluid in such systems, including the tracers are also disclosed.12-02-2010
20110027803Compositions and Methods for Maintenance of Fluid Conducting and Containment Systems - Latently detectable small molecules, or ‘labels’, used for monitoring of treatment substances in fluid conducting and containment systems. A composition comprising the treatment substance and the label, a method of manufacturing the composition, a method and kit for use in monitoring the treatment substances in a fluid conducting and containment system, and a method for treating such a system using the composition are also disclosed.02-03-2011
20110151576METHOD TO ASSESS MULTIPHASE FLUID COMPOSITIONS - A method for the assessment of a multiphase (aqueous and organic) sample phase, the method comprising adding at least one detection molecule to the multiphase sample; detecting a signal emitted from the detection molecule/multiphase sample mixture, the signal being detectably different when the at least one detection molecule is present in one of either an organic phase, an aqueous phase or an interface between said organic phase and said aqueous phase of the multiphase sample; and analysing the detected signal to assess the properties of a phase or an interface between phases. A system for use in such a method, use of at least one detection molecule for the assessment of a multiphase sample, and a composition for use in the assessment of a multiphase sample are also disclosed.06-23-2011

Emma Reyes-Rosales, Mexico City MX

Patent application numberDescriptionPublished
20110105346Universal fingerprinting chips and uses thereof - The present invention discloses a designing strategy for constructing a set of probes useful for analyzing all or most prokaryotic and eukaryotic genomes. A set of capture probes with optimal fingerprinting properties and highly representative of all possible sequences of an organism can be selected by six sequential steps. Fingerprinting potential of such probes is validated by phylogenetic analysis, which generates results that strongly correlate with phylogenetic trees produced by sequence alignment. The probes generated by the instant methods can be used for detecting an organism, for establishing phylogenetic relationships between different organisms, for detection of single nucleotide polymorphisms and a wide variety of other applications that require genetic analysis.05-05-2011

Emma Rozadas, Goteberg SE

Patent application numberDescriptionPublished
20100231372METHOD FOR COMMUNICATING A DEVIATION OF A VEHICLE PARAMETER - A method, a device and a system for communicating in a vehicle at least one deviation of a measured actual vehicle parameter value from its predetermined value to a driver involve determining an amount of the deviation, color-coding the amount of deviation, and communicating the amount of deviation to the driver by using the color-code. Determining the amount of deviation includes weighting a calculated difference between the measured actual vehicle parameter value and the predetermined vehicle parameter value with a weighting factor. A vehicle or more particularly a truck may include such a device and such a system and a computer programmed for performing such a method and computer readable medium comprising a program for performing such a method can be provided.09-16-2010

Emma Svenbrant, Gothenburg SE

Patent application numberDescriptionPublished
20080296875Airbag for Protecting a Vehicle Occupant - An airbag for protecting a vehicle occupant comprising a first and a second material layer each having edge regions, wherein the first and the second layers are sewn together along the edge regions. A fastening section adapted for attaching to a part of the vehicle and connecting to a gas generator configured to inflate the airbag with a gas in response to an accident. A first and a second chamber region disposed opposite a dividing seam, wherein each of the material layers includes a first and a second material section each matched to one of the first or second chamber regions.12-04-2008

Emma Terricabras Belart, Barcelona ES

Patent application numberDescriptionPublished
20090130090N-amide Derivatives of 8-Azabicyclo[3.2.1]OCT-3-YL AS CCR1 Antagonists - New antagonists of the interaction between the CCR1 Chemokine receptor and its ligands, including MIP-1α (CCL3), represented by formula (I) are disclosed, as well as pharmaceutical compositions comprising them and their use in therapy for the treatment of pathological conditions or diseases susceptible of being improved by antagonism of the CCR1 receptor.05-21-2009
20110212945AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS - The present disclosure relates to new azabiphenylaminobenzoic acid derivatives of formula (I); as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy as inhibitors of the dehydroorotate dihydrogenase (DHODH).09-01-2011

Patent applications by Emma Terricabras Belart, Barcelona ES

Emma Tevaarwerk, Evanston, IL US

Patent application numberDescriptionPublished
20090181172LITHOGRAPHY OF NANOPARTICLE BASED INKS - An ink composition comprising: a plurality of metallic nanoparticles suspended in a carrier, wherein the carrier comprises water and at least one organic solvent miscible with water, and wherein the composition is formulated for slow dry rate and proper viscosity for DPN. Also, a method comprising: depositing a composition onto a cantilever, wherein the composition comprises a plurality of metallic nanoparticles suspended in a carrier, wherein the carrier comprises water and at least one organic solvent miscible with water. The composition can be used in direct writing onto surfaces to form patterns and arrays using cantilevers, microcontact printing, ink jet printing, and other methods. The composition is particularly useful for preparing nanoscale features and forming high quality continuous conductive lines and dots, including silver based lines and dots. Applications include surface repair.07-16-2009

Emma Vickerstaffe, Cambridge GB

Patent application numberDescriptionPublished
20100093718 Compounds - The invention relates to new bicyclic heterocyclic derivative compounds of Formula (I), to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer The compounds of Formula (I) are inhibitors of FGFR, VEGFR or PDGFR.04-15-2010
20100120761Bicyclic Heterocyclic Compounds as FGFR Inhibitors - The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.05-13-2010

Emma Vickerstaffe, Baldock GB

Patent application numberDescriptionPublished
20100286113BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS - The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R11-11-2010
20100331296BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS - The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R12-30-2010
20120035152BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS - The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R02-09-2012
20120035153BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS - The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R02-09-2012

Emma Widehall, Vastra Frolunda SE

Patent application numberDescriptionPublished
20080282911Waste Bin Having Compacting Means - A waste bin (11-20-2008